SciELO - Scientific Electronic Library Online

vol.24 issue3An appraisal of the isoniazid resistant tuberculosis in Colombia: a underestimated problem in Colombia?A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (SARS CoV-2) author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google



Print version ISSN 0123-9392


MARTINEZ, José W. et al. Microbiological characteristics of infections in a group of colombian patients with oncological diagnosis, 2014 - 2016. Infect. [online]. 2020, vol.24, n.3, pp.182-186. ISSN 0123-9392.


We aimed to describe the microbiological characteristics of infections in patients from an oncological center during 2.014-2.016.


In this cross-sectional descriptive study, a total of 7.837 cultures corresponding to 1.216 patients were included. Microbiological and sociodemographic data were taken from cancer diagnosed patients admitted to Oncólogos de Occidente S.A. in Pereira, Armenia, Manizales and Cartago from January 2.014 to December 2.016. The bacterial resistance profiles were defined according to the CLSI guideline. Culture foci were blood, urine, tissue biopsies, skin and soft tissues, mucous membranes and feces.


The culture-positive rate was 27,94%. Amongst 2.190 isolates, Escherichia coli (22,42%) was the most frequent, followed by Klebsiella pneumonia (21,27%), Pseudomona aeruginosa (13,83%) and Staphylococcus aureus (5,11%). The most common mechanisms of antimicrobial resistance in Gram-negatives were Extended-Spectrum β-Lactamase (45,45%) and AmpC-type β-lactamases (37,71%).


Up to nearly one-third of our participants’ cultures were positive and a vast majority were gram-negatives, provided with ESBLs or AmpCs which in oncological patients it is a catastrophic outcome. We recommend to establish antibiotic dispensing policies thus achieving a microbiological risk control and improve the epidemiological surveillance. Empirical use of beta-lactams with extended spectrum or cephalosporins of 1 to 3 generation is not recommended due to the high resistance found.

Keywords : Neoplasms; nosocomial infection; microbial drug resistance; cancer care facilities; antibiotics.

        · abstract in Spanish     · text in English     · English ( pdf )